Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis

Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis

NCT00213564 ·Status: COMPLETED

A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting

NCT05487703 ·Status: COMPLETED

Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)

NCT01481493 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis

NCT01071798 ·Status: COMPLETED

An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

NCT07029555 ·Status: RECRUITING ·Phase: PHASE1

An Open Label Extension Study in Participants With Rheumatoid Arthritis

NCT00837811 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis

NCT00380744 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis

NCT01834807 ·Status: COMPLETED

Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients

NCT02116504 ·Status: UNKNOWN ·Phase: NA

Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy

NCT00844714 ·Status: COMPLETED ·Phase: NA

Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital

NCT00854321 ·Status: COMPLETED

An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor

NCT01557348 ·Status: COMPLETED

A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis

NCT04740814 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis

NCT00074438 ·Status: COMPLETED ·Phase: PHASE2

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed

NCT05533125 ·Status: COMPLETED ·Phase: PHASE3

Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)

NCT00396812 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis

NCT06003283 ·Status: RECRUITING ·Phase: PHASE4

Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis

NCT01244958 ·Status: COMPLETED ·Phase: PHASE3

A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis

NCT01382940 ·Status: COMPLETED ·Phase: PHASE4

Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis

NCT01593332 ·Status: COMPLETED ·Phase: PHASE4

Purify Antigen-specific B Cells From Patients With Rheumatoid Arthritis

NCT05203952 ·Status: UNKNOWN

Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis

NCT02699892 ·Status: COMPLETED

Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)

NCT01235598 ·Status: COMPLETED ·Phase: PHASE3

Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

NCT01021735 ·Status: COMPLETED ·Phase: PHASE4

A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy

NCT00785928 ·Status: COMPLETED ·Phase: PHASE2